Trademark: 90089895
Word
COVID-SEROINDEX
Status
Dead
Status Code
606
Status Date
Monday, September 19, 2022
Serial Number
90089895
Mark Type
4000
Filing Date
Monday, August 3, 2020
Published for Opposition
Tuesday, December 21, 2021
Abandoned Date
Monday, September 19, 2022

Trademark Owner History
Kantaro Biosciences LLC - Owner At Publication

Classifications
1 Diagnostic agents, preparations and substances other than for medical or veterinary purposes; Diagnostic preparations and reagents for scientific or medical research use; Diagnostic preparations and reagents for clinical or medical laboratory use; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting and analyzing antibodies, enzymes, antigens, diseases, viruses and infections for scientific, laboratory or medical research use; Test kits consisting of diagnostic preparations, reagents, assays, solutions and buffers for clinical or medical laboratory testing and analysis of SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Test kits comprised of diagnostic preparations, reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens for use in infection, virus and disease detection for scientific or medical research use; Diagnostic preparations for scientific or research purposes related to vaccines in the fields of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Diagnostic assays, media, solutions and buffers for clinical use; Diagnostic agents for carrying out serologic tests for clinical purposes; Diagnostic reagents for serologic tests of infections for clinical purposes; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for clinical and research purposes; Diagnostic preparations for clinical purposes for detecting the presence of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; all the foregoing related to the detection, diagnosis, testing, prevention and/or treatment of SARS-CoV-2, COVID-19 and antibodies, antigens, diseases, illnesses, viruses, disorders and/or infections related to SARS-CoV-2 or COVID-19

Trademark Events
Sep 19, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 19, 2022
Abandonment - No Use Statement Filed
Feb 15, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 21, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 21, 2021
Published For Opposition
Dec 1, 2021
Notification Of Notice Of Publication E-Mailed
Nov 14, 2021
Approved For Pub - Principal Register
Aug 27, 2021
Teas/Email Correspondence Entered
Aug 26, 2021
Correspondence Received In Law Office
Aug 26, 2021
Teas Response To Office Action Received
Mar 20, 2021
Notification Of Non-Final Action E-Mailed
Mar 20, 2021
Non-Final Action E-Mailed
Mar 20, 2021
Non-Final Action Written
Feb 26, 2021
Notification Of Non-Final Action E-Mailed
Feb 26, 2021
Non-Final Action E-Mailed
Feb 26, 2021
Non-Final Action Written
Feb 10, 2021
Assigned To Examiner
Sep 1, 2020
New Application Office Supplied Data Entered In Tram
Aug 6, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24